GlassScriptPhysician profile
Atul S Shetty
NPI 1801884556
$14,599.88
in general payments reported to CMS, 2019-2025
65 companies · $2,773 in 2025
The $2,773 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,468 · 2020: $2,139 · 2021: $1,680 · 2022: $1,841 · 2023: $1,612 · 2024: $2,087 · 2025: $2,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,468 · Education: $4.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,467.74 |
| Education | $4.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,659.94 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $1,600.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,139.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,031.97 | 2019-2025 | Farxiga, Airsupra, Brilinta |
| Janssen Pharmaceuticals, INC | $810.80 | 2019-2024 | Xarelto |
| Amgen INC. | $741.20 | 2019-2025 | Repatha, Evenity, Otezla |
| Inari Medical, INC. | $733.96 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $630.08 | 2019-2024 | Mounjaro, Emgality, Jardiance |
| Allergan, INC. | $493.83 | 2019-2020 | |
| Daiichi Sankyo INC. | $446.03 | 2019-2025 | Injectafer |
| Abbott Laboratories | $398.06 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $395.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $344.59 | 2019-2023 | |
| Medtronic, INC. | $266.96 | 2023-2025 | Hawkone, Abre |
| Axsome Therapeutics, INC. | $213.59 | 2024-2025 | Auvelity, Sunosi |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.